About this FactMed analysis covering adverse side effect reports of CHINOTAL (PENTOXIFYLLINE) patients who developed PHARMACEUTICAL PRODUCT COMPLAINT.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking CHINOTAL (PENTOXIFYLLINE) reported PHARMACEUTICAL PRODUCT COMPLAINT to the FDA. A total of 5 CHINOTAL (PENTOXIFYLLINE) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CHINOTAL (PENTOXIFYLLINE) and PHARMACEUTICAL PRODUCT COMPLAINT. In doing so, we compare CHINOTAL (PENTOXIFYLLINE) with other drugs that cause PHARMACEUTICAL PRODUCT COMPLAINT, to help you evaluate whether or not CHINOTAL (PENTOXIFYLLINE) causes PHARMACEUTICAL PRODUCT COMPLAINT. Likewise, this page shows the most highly-reported side effects of CHINOTAL (PENTOXIFYLLINE), so you can see if PHARMACEUTICAL PRODUCT COMPLAINT ranks among CHINOTAL (PENTOXIFYLLINE)'s most well-known side effects.
Summary Statistics
Reports of CHINOTAL (PENTOXIFYLLINE) causing PHARMACEUTICAL PRODUCT COMPLAINT: 1
Reports of any side effect of CHINOTAL (PENTOXIFYLLINE) : 5
Percentage of CHINOTAL (PENTOXIFYLLINE) patients where PHARMACEUTICAL PRODUCT COMPLAINT is a reported side effect: 20.0000%

FDA reports of any drug causing PHARMACEUTICAL PRODUCT COMPLAINT : 32129
Average percentage for all medicated patients where PHARMACEUTICAL PRODUCT COMPLAINT is reported as a complication: 0.2014%

Physician opinion on CHINOTAL (PENTOXIFYLLINE) as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CHINOTAL (PENTOXIFYLLINE):
( 0 patients )
Drugs with high FDA adverse event association with PHARMACEUTICAL PRODUCT COMPLAINT:

FORTEO (3551 patients)
FACTOR IX COMPLEX (3520 patients)
ANTIHEMOPHILIC FACTOR (HUMAN) (2363 patients)
ADVAIR DISKUS 100/50 (2016 patients)
ALBUTEROL (1280 patients)
ASPIRIN (1123 patients)
HUMALOG (1101 patients)
LANTUS (1054 patients)
KOATE (958 patients)
KONYNE (944 patients)
DURAGESIC-100 (916 patients)
SYNTHROID (831 patients)
IMITREX (809 patients)
LIPITOR (803 patients)
HEMOFIL (747 patients)
PROPLEX T (728 patients)
ALLI (687 patients)
FLOVENT (652 patients)
SINGULAIR (641 patients)
HUMULIN N (631 patients)
ADVAIR HFA (611 patients)
LISINOPRIL (575 patients)
NEURONTIN (568 patients)
DURAGESIC (517 patients)
DIGOXIN (511 patients)
ATENOLOL (500 patients)
NEXIUM (484 patients)
FENTANYL TRANSDERMAL SYSTEM (482 patients)
LASIX (472 patients)
NORVASC (470 patients)
COUMADIN (459 patients)
HUMULIN R (443 patients)
FACTOR VIII (AVENTIS BEHRING) (FACTOR VIII) (431 patients)
NO CONCURRENT MEDICATION (426 patients)
FACTOR VIII (ARMOUR) (FACTOR VIII) (414 patients)
XANAX (408 patients)
SEREVENT (407 patients)
PLAVIX (401 patients)
FUROSEMIDE (398 patients)
FLONASE (395 patients)
ZOLOFT (390 patients)
PREVACID (387 patients)
HYDROCHLOROTHIAZIDE (380 patients)
ZOCOR (370 patients)
METFORMIN HCL (367 patients)
PREDNISONE (363 patients)
FENTANYL (360 patients)
DILANTIN (353 patients)
TOPROL-XL (345 patients)
HUMULIN 70/30 (341 patients)
GABAPENTIN (331 patients)
CELEBREX (329 patients)
FOSAMAX (325 patients)
COMBIVENT (323 patients)
PAXIL (320 patients)
LEVOTHYROXINE SODIUM (315 patients)
SPIRIVA (315 patients)
NICORETTE (306 patients)
ZYRTEC (299 patients)
PREMARIN (297 patients)
PROTONIX (292 patients)
OXYCONTIN (279 patients)
OMEPRAZOLE (277 patients)
MULTI-VITAMIN (275 patients)
PRILOSEC (272 patients)
WARFARIN SODIUM (269 patients)
BUPROPION HCL (254 patients)
CLONAZEPAM (253 patients)
AMBIEN (250 patients)
EVISTA (248 patients)
DIOVAN (247 patients)
LEXAPRO (245 patients)
CALCIUM GLUCONATE (244 patients)
WELLBUTRIN XL (243 patients)
CALCIUM (238 patients)
POTASSIUM CHLORIDE (234 patients)
ALPRAZOLAM (233 patients)
ALLEGRA (232 patients)
ATIVAN (232 patients)
PROAIR HFA (230 patients)
PROZAC (228 patients)
VENTOLIN (228 patients)
LEVOXYL (227 patients)
FOLIC ACID (226 patients)
LAMICTAL (226 patients)
ACTOS (225 patients)
LORAZEPAM (224 patients)
KLONOPIN (214 patients)
GLUCOPHAGE (210 patients)
VITAMIN E (205 patients)
WELLBUTRIN (199 patients)
PERCOCET (198 patients)
COREG (197 patients)
ZANTAC (194 patients)
VICODIN (194 patients)
BYETTA (191 patients)
HUMALOG MIX 75/25 (189 patients)
INSULIN (188 patients)
GLIPIZIDE (186 patients)
FLUOXETINE (183 patients)
MORPHINE SULFATE (182 patients)
NARDIL (178 patients)
NEUPRO (174 patients)
HEPARIN (173 patients)
AVANDIA (172 patients)
SIMVASTATIN (171 patients)
CLIMARA (170 patients)
COZAAR (169 patients)
OXYCODONE HCL (168 patients)
PHENYTOIN (168 patients)
TOPAMAX (167 patients)
ACTONEL (167 patients)
TRAZODONE HCL (166 patients)
FACTOR VIII (BAXTER) (FACTOR VIII) (163 patients)
OPTICLIK (INSULIN INJECTION PEN) (163 patients)
VALIUM (163 patients)
NOVOLOG (162 patients)
ALTACE (162 patients)
IBUPROFEN (159 patients)
MULTIVITAMIN (159 patients)
VITAMIN D (158 patients)
XALATAN (158 patients)
FACTOR VIII (ALPHA THERAPEUTICS) (FACTOR VIII) (157 patients)
CYMBALTA (155 patients)
KOGENATE FS (155 patients)
PREDNISONE TAB (155 patients)
HUMATROPE (155 patients)
ATROVENT (154 patients)
VASOTEC (153 patients)
ACETAMINOPHEN (151 patients)
VERAPAMIL (150 patients)
FLOLAN (148 patients)
TEGRETOL (145 patients)
PAROXETINE HCL (143 patients)
SERTRALINE (142 patients)
ZETIA (138 patients)
TYLENOL (135 patients)
KEPPRA (135 patients)
PAXIL CR (134 patients)
PROVENTIL (133 patients)
PRAVACHOL (133 patients)
BEXTRA (131 patients)
UNKNOWN MEDICATION (130 patients)
NITROGLYCERIN (130 patients)
NASONEX (130 patients)
ALLOPURINOL (130 patients)
GLYBURIDE (129 patients)
FLUTICASONE PROPIONATE (129 patients)
ACIPHEX (129 patients)
DILANTIN KAPSEAL (129 patients)
WELLBUTRIN SR (127 patients)
SEROQUEL (127 patients)
VITAMINS (126 patients)
VIOXX (126 patients)
DIAZEPAM (124 patients)
AMITRIPTYLINE HCL (124 patients)
CRESTOR (122 patients)
FLOMAX (120 patients)
CLONIDINE (119 patients)
THYROID TAB (117 patients)
RANITIDINE (116 patients)
CELEXA (114 patients)
METFORMIN (112 patients)
DEPAKOTE (112 patients)
LORTAB (112 patients)
ENALAPRIL MALEATE (111 patients)
ENDOSOL EXTRA (110 patients)
VIAGRA (109 patients)
PROVENTIL-HFA (109 patients)
SPIRONOLACTONE (109 patients)
DILTIAZEM (108 patients)
METOPROLOL (108 patients)
TRAMADOL HCL (108 patients)
EFFEXOR (107 patients)
BENADRYL (103 patients)
TRICOR (102 patients)
METHOTREXATE (102 patients)
METOPROLOL TARTRATE (102 patients)
AVAPRO (101 patients)
ESTRADIOL (101 patients)
AMLODIPINE (101 patients)
CLARITIN (100 patients)
HUMALOG PEN (100 patients)
ULTRAM (100 patients)
LYRICA (99 patients)
METOPROLOL SUCCINATE (99 patients)
FLEXERIL (99 patients)
COMMIT (98 patients)
ASCORBIC ACID (98 patients)
SINEMET (98 patients)
PROPRANOLOL (95 patients)
VYTORIN (95 patients)
REQUIP (94 patients)
AMARYL (93 patients)
OXYGEN (93 patients)
OPTIPEN (INSULIN PUMP) (93 patients)
THEOPHYLLINE (92 patients)
IMDUR (92 patients)
FORTEO PEN (FORTEO PEN) PEN, DISPOSABLE (92 patients)
CARBAMAZEPINE (92 patients)
LOVASTATIN (91 patients)
EFFEXOR XR (91 patients)
LOTREL (91 patients)
CARDIZEM (90 patients)
LOPRESSOR (90 patients)
HEPARIN SODIUM (89 patients)
LANOXIN (88 patients)
SERETIDE (88 patients)
ACETYLSALICYLIC ACID SRT (88 patients)
AVODART (87 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for CHINOTAL (PENTOXIFYLLINE)


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about PHARMACEUTICAL PRODUCT COMPLAINT and CHINOTAL (PENTOXIFYLLINE), post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CHINOTAL (PENTOXIFYLLINE), post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CHINOTAL (PENTOXIFYLLINE). This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CHINOTAL (PENTOXIFYLLINE) experts. If you are a healthcare provider experienced in prescribing CHINOTAL (PENTOXIFYLLINE), please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use